Erste Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.99M	Sell	180,300 -62,000	-26%	-$1.37M	0.03%	304
2025 Q1	$4.14M	Hold	242,300	–	–	0.05%	240
2024 Q4	$4.11M	Hold	242,300	–	–	0.05%	254
2024 Q3	$3.8M	Hold	242,300	–	–	0.05%	265
2024 Q2	$3.97M	Hold	242,300	–	–	0.05%	250
2024 Q1	$4.41M	Buy	242,300 +94,000	+63%	+$1.71M	0.06%	240
2023 Q4	$4.65M	Buy	148,300 +15,700	+12%	+$493K	0.07%	232
2023 Q3	$2.85M	Buy	132,600 +42,000	+46%	+$904K	0.05%	246
2023 Q2	$2.17M	Hold	90,600	–	–	0.04%	279
2023 Q1	$1.69M	Hold	90,600	–	–	0.03%	297
2022 Q4	$1.45M	Hold	90,600	–	–	0.03%	306
2022 Q3	$1.46M	Hold	90,600	–	–	0.03%	313
2022 Q2	$1.29M	Hold	90,600	–	–	0.03%	325
2022 Q1	$2.21M	Sell	90,600 -10,900	-11%	-$266K	0.04%	282
2021 Q4	$2.43M	Hold	101,500	–	–	0.04%	279
2021 Q3	$1.72M	Hold	101,500	–	–	0.03%	288
2021 Q2	$2.45M	Hold	101,500	–	–	0.05%	266
2021 Q1	$2.61M	Hold	101,500	–	–	0.06%	239
2020 Q4	$5.46M	Sell	101,500 -21,000	-17%	-$1.13M	0.15%	167
2020 Q3	$4.95M	Buy	122,500 +18,500	+18%	+$748K	0.17%	146
2020 Q2	$5.01M	Sell	104,000 -11,000	-10%	-$530K	0.2%	132
2020 Q1	$4.75M	Buy	115,000 +57,800	+101%	+$2.39M	0.28%	108
2019 Q4	$2.52M	Buy	57,200 +11,000	+24%	+$484K	0.11%	179
2019 Q3	$1.7M	Hold	46,200	–	–	0.09%	203
2019 Q2	$1.22M	Hold	46,200	–	–	0.06%	230
2019 Q1	$1.23M	Hold	46,200	–	–	0.07%	227
2018 Q4	$714K	Buy	+46,200	New	+$714K	0.05%	268